![](https://www.discoverx.com/content/uploads/2023/05/COVID-19_Small-Card-Image-310x174.jpg)
Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays
Read MoreShowing all 7 results
Accelerate COVID-19 drug discovery & development programs targeting proinflammatory cytokines & others with qualified assays
Read MoreReady-to-use kits for biologics characterization, MOA confirmation, NAbs detection, stability studies, & potency testing
Read MoreAccelerate cancer immunotherapy drug development with easy-to-use, functional cell-based assays targeted at checkpoint receptors
Read MoreSimple, non-radioactive, & dye-free cytotoxicity assays to specifically measure target cell death
Read MoreReady-to-use, cell-based bioassay kits to measure direct cell death for screening, characterization, & potency testing
Read MoreAccelerate cancer immunotherapeutic discovery & development with cell-based, clinically relevant assays
Read MoreSimple, orthogonal reporter-based assays for screening & understanding therapeutic MOAs
Read More